Holly Willis Malone ARNP

Recommended Articles

• The Perks of Being a Nurse

  When it comes to jobs and careers, many people think the most important benefit is a high paying salary. But, this is not the case with the nursing career. Yes, of course, money is important and the salary that nurses get is comparable to many other professions. But, the perks of the career do not...

• What is the Correlation Between Urinary Incontinence and Diet?

  Urinary incontinence can be controlled to a large extent by one's diet, even though there is nothing called an ‘incontinence diet’. Many times doctors advise their patients to avoid a particular food or drink to improve the symptoms of urinary incontinence. These foods may differ depending on...

• Social Networking Sites May Reflect the Realities of Your Life

  Social networking sites like Facebook, Instagram and Twitter may reflect the realities of your personality, according to a study published in the journal Psychological Science. This was revealed by group of researchers who tried to determine whether people fake it on social networking sites...

• These Young Adults with Cystic Fibrosis Raise Awareness Through their Careers

  Treatment and management of Cystic Fibrosis (CF) has come a long way. It used to result in children dying at very early ages, but now they can live much longer and even flourish well into adulthood. This is a result of novel treatment methods, enhanced specialized care, dietary changes, and overall...

• What Conditions Warrant Occupational Therapy?

  In general, therapy refers to an attempt of diagnosing a health problem upon identification. Various forms of therapy have been created to address different health problems. Occupational therapy (OT) is among the newer forms of therapies which is very closely related to physical therapy (PT), but is...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...